Abstract Background: Gabapentin is considered a safe and well-tolerated antipileptic drug (AED) with a favorable pharmacokinetic profile and a broad therapeutic index. However, recent studies have used higher doses and faster titration schedules than those used in the pivotal trials that established the efficacy of gabapentin in the treatment of partial seizures. Gabapentin (gab-ah-PEN-tin) is the generic name (non-brand name) of the seizure medicine Neurontin (nur-ON-tin) used in the United States, Canada, the UK, and some other countries. Another commonly used name for gabapentin is GBP. Exacerbation of seizures in idiopathic generalized epilepsy has been demonstrated for several commonly used antiepileptic drugs, including vigabatrin, tiagabine, carbamazepine, and possibly gabapentin. Phenytoin and vigabatrin also have been implicated in worsening of seizures, particularly generalized seizures, whereas gabapentin has been associated repeatedly with precipitation of myoclonic jerks. Gabapentin for Seizures: Drugs [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2024 Oct. Table 9, Summary of Recommendations in Included Guidelines. Gabapentin has shown efficacy in treating several types of seizures, including partial seizures and secondary generalized seizures. Its action as a GABA analog allows increased inhibition in the central nervous system, which is beneficial for patients with focal seizures originating in specific brain regions. Study with Quizlet and memorize flashcards containing terms like Which of the following statements is true concerning epilepsy? a. Epileptic seizures can be recorded on electrocardiogram. b. Seizure activities are estimated to affect approximately 10% of the population. c. The majority of epileptic patients have idiopathic epilepsy. d. The most common generalized seizures are temporal lobe Gabapentin is well tolerated by patients with generalized seizures. The results of this study show a trend toward an effect of gabapentin in reducing the frequency of generalized tonic-clonic seizures and suggest that further exploration of high dose gabapentin in generalized epilepsy is warranted. Several new antiepileptic drugs (AEDs) are effective in treating selected patients with partial or mixed seizure disorders, but evidence for their efficacy in patients with generalized epilepsy One guideline recommends against the use of gabapentin in people with myoclonic seizures or people with epilepsy with myoclonic-atonic seizures. One guideline states that there is insufficient evidence to consider gabapentin instead of carbamazepine in patients with new-onset focal epilepsy or unclassified generalized tonic-clonic seizures. Gabapentin is available in Canada by prescription only. Known as Neurontin Uses Effective against partial seizures (including secondary generalized tonic-clonic). Somewhat effective against primary generalized tonic-clonic seizures. Ineffective or worsens absence, myoclonic or tonic / atonic type seizures. How to Use Do not increase or decrease the dose without your doctor’s approval. Do not Studies have demonstrated the effectiveness of gabapentin as an adjunctive treatment for various types of seizures, including partial onset seizures and generalized tonic-clonic seizures. The new antiepileptic medications are prescribed for the treatment of patients with seizure disorders since 17 years ago. Gabapentin (GBP) was approved on January 1994 as adjunctive treatment in patients 12 years or older with partial seizures, with Abstract Background: Epilepsy is one of the most common chronic neurological disorders, affecting more than 50 million people globally. In this review we summarised the evidence from randomised controlled trials of gabapentin used as monotherapy for the treatment of focal epilepsy, both newly diagnosed and drug-resistant, with or without secondary generalisation. Gabapentin is FDA-approved as an add-on treatment for focal-onset seizures, helping improve seizure control alongside other therapies. This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of gabapentin monotherapy for people with epileptic partial seizures with and without secondary generalisation. Studies have demonstrated the effectiveness of gabapentin as an adjunctive treatment for various types of seizures, including partial onset seizures and generalized tonic-clonic seizures. Gabapentin is 1 of many antiseizure medications available for the treatment of epilepsy in adults; however, there are potential risks associated with its use. Therefore, it is important to determine the place of therapy of gabapentin in the treatment of epilepsy. Gabapentin is well tolerated by patients with generalized seizures. The results of this study show a trend toward an effect of gabapentin in reducing the frequency of generalized tonic-clonic seizures and suggest that further exploration of high dose gabapentin in generalized epilepsy is warranted. Gabapentin is well tolerated by patients with generalized seizures. The results of this study show a trend toward an effect of gabapentin in reducing the frequency of generalized tonic-clonic seizures and suggest that further exploration of high dose gabapentin in generalized epilepsy is warranted.
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |